Aptar scoops up two pharma services firms in $50m deal

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/AndreyPopov)
(Image: Getty/AndreyPopov)

Related tags: Aptar Group, Analytical testing, Drug development

Aptar Group acquires two pharmaceutical services companies, Nanopharm and Gateway Analytical, to boost its analytical, testing, and development capabilities.

Headquartered in Crystal Lake, IL, Aptar​ provides a range of dispensing, sealing, and active packaging solutions and this week purchased the two companies for a combined enterprise value of approximately $50m.

Nanopharm provides analytical and drug development services with a focus on orally inhaled and nasal drug products and is located in Newport, UK, while Gibsonia, PA-based Gateway Analytical provides particulate detection and predictive analytical services to customers developing injectable medicines.

According to Aptar, the acquisitions are in line with the company’s strategy to expand its services portfolio.

The addition will enable the company to collaborate with customers earlier, supporting drug formulation and delivery.

Aptar has previously voiced plans to expand globally​ as part of a multi-year investment plan in response to expected growth in the injectable market driven by biologics and vaccines.

Related news

Show more

Related products

show more

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Related suppliers

Follow us

Products

View more

Webinars